Figure1
This text is not available.*
Paxil Tablet, Film Coated, Extended Release
Product Images NDC 60505-4378
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 10 technical images submitted to the FDA as part of the official labeling for Paxil (NDC 60505-4378). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Apotex Corp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure2
The text provided is a list of drugs with their daily dosage and a mention of fold change and 90% C! in relation to a reference. It is not possible to provide a useful description with this information.*
Figure3
Paxilcr12.5mg30counttabletlabel Gsk
This is the description for a medication called Paroxetine HCI. It comes in the form of controlled-release tablets, and each tablet contains 12.5 mg of paroxetine hydrochloride. The medication is distributed by Apotex Corp. and was manufactured by GlaxoSmithKline. It is recommended to store the tablets at or below 25°C (77°F). The dosage information can be found in the accompanying prescribing information. It is important to use safety closures when dispensing the product, unless otherwise directed by a physician or requested by the purchaser.*
Paxilcr12.5mg30counttabletlabel
This is a prescription drug information about Paroxetine Extended-Release Tablets. It advises to store the medication at or below 25°C (77°F), and provides the dosage information in the accompanying prescribing information. Safety closures are recommended when dispensing unless directed by the physician or purchaser. The drug is manufactured by Apotex Corp. The NDC number and tablet count are provided.*
Paxilcr25mg30counttabletlabel Gsk
PAROXETINE HCI CONTROLLED-RELEASE TABLETS are manufactured by GlaxoSmithKline and are distributed by Apotex Corp. Each controlled-release tablet contains 25mg of Paroxetine hydrochloride which is equivalent to 26mg paroxetine. This product should be stored at or below 25°C [77°F). Safety closures should be used when dispensing this product unless otherwise directed by a physician or requested by the purchaser. The tablets come in 30 counts and the accompanying prescribing information should be referenced for dosage. A108017 Rev. 7/12. Made in Canada.*
Paxilcr25mg30counttabletlabel
This is a description of a medication called PAXILCZ® PAROXETINE EXTENDED-RELEASE TABLETS. Each tablet contains 25mg of paroxetine hydrochloride. The medication must be stored at or below 25°C (77°F). The National Drug Code (NDC) for this medication is 60505-4378-3. The package contains 30 tablets and is manufactured by Apotex Corp. The accompanying prescribing information should be consulted for dosage information. The product comes with safety closures and should be used as directed by the physician or requested by the purchaser.*
Paxilcr37.5mg30counttabletlabel Gsk
This is a description of a medication for Paroxetine HCI in the form of controlled-release tablets. The tablets must be stored at or below 25°C (77°F). Each tablet containing paroxetine hydrochloride is equivalent to 37.5 mg paroxetine. The manufacturer is GlaxoSmithKline and it is distributed by Apotex Corp. The medication information includes important advice to use safety closures when dispensing this medication and to check the dosage information provided with the pill.*
Paxilcr37.5mg30counttabletlabel
This is a prescription drug package for extended-release paroxetine tablets containing 37.5mg of paroxetine hydrochloride, manufactured by Apotex Corp. The package includes 30 tablets and has important safety instructions for prescribing and dispensing. It should be stored at or below 25°C (77°F).*
Structure
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
